Vistagen Therapeutics, Inc. Annual Revenues in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Vistagen Therapeutics, Inc. quarterly/annual Revenues history and growth rate from 2010 to 2022.
  • Vistagen Therapeutics, Inc. Revenues for the quarter ending March 31, 2023 was $176K, a 351% increase year-over-year.
  • Vistagen Therapeutics, Inc. Revenues for the twelve months ending March 31, 2023 was -$227K, a 120% decline year-over-year.
  • Vistagen Therapeutics, Inc. annual Revenues for 2022 was -$227K, a 120% decline from 2021.
  • Vistagen Therapeutics, Inc. annual Revenues for 2021 was $1.11M, a 1.79% increase from 2020.
  • Vistagen Therapeutics, Inc. annual Revenues for 2020 was $1.09M.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$227K -$1.34M -120% Apr 1, 2022 Mar 31, 2023 10-K 2023-06-28
2021 $1.11M +$19.5K +1.79% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 $1.09M +$1.09M Apr 1, 2020 Mar 31, 2021 10-K 2021-06-29
2019 $0 Apr 1, 2019 Mar 31, 2020 10-K 2021-06-29
2017 $0 -$1.25M -100% Apr 1, 2017 Mar 31, 2018 10-K 2018-06-26
2016 $1.25M +$1.25M Apr 1, 2016 Mar 31, 2017 10-K 2018-06-26
2015 $0 Apr 1, 2015 Mar 31, 2016 10-K 2017-06-29
2012 $200K -$1.14M -85.1% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-25
2011 $1.34M -$729K -35.2% Apr 1, 2011 Mar 31, 2012 10-K 2013-07-18
2010 $2.07M Apr 1, 2010 Mar 31, 2011 10-K 2012-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.